Alpha 2.0
Login Register
» Articles » PMID: 29373664

Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits

Overview
Journal Clin Infect Dis
Publisher Oxford University Press
Specialty Infectious Diseases
Date 2018 Jan 27
PMID 29373664
Citations 39
Authors
Sarah Kabbani
Adam L Hersh
Daniel J Shapiro
Katherine E Fleming-Dutra
Andrew T Pavia
Lauri A Hicks
Affiliations
Soon will be listed here.
Abstract

The Food and Drug Administration warned against fluoroquinolone use for conditions with effective alternative agents. An estimated 5.1% of adult ambulatory fluoroquinolone prescriptions were for conditions that did not require antibiotics, and 19.9% were for conditions where fluoroquinolones are not recommended first-line therapy. Unnecessary fluoroquinolone use should be reduced.

Citing Articles

AI driven decision support reduces antibiotic mismatches and inappropriate use in outpatient urinary tract infections.

Shapiro Ben David S, Romano R, Rahamim-Cohen D, Azuri J, Greenfeld S, Gedassi B NPJ Digit Med. 2025; 8(1):61.

PMID: 39870860 PMC: 11772748. DOI: 10.1038/s41746-024-01400-5.

Fluoroquinolones and Biofilm: A Narrative Review.

Geremia N, Giovagnorio F, Colpani A, De Vito A, Botan A, Stroffolini G Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770514 PMC: 11679785. DOI: 10.3390/ph17121673.

Analyzing the relationship between socioeconomic deprivation and outpatient Medicare Part D fluoroquinolone claim rates in Texas.

Al Mohajer M, Samarasundera E, Goncalves J, Heath A Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e40.

PMID: 38562515 PMC: 10983052. DOI: 10.1017/ash.2024.38.

Colloidal Chiral Carbon Dots: An Emerging System for Chiroptical Applications.

Zhao Y, Xie J, Tian Y, Mourdikoudis S, Fiuza-Maneiro N, Du Y Adv Sci (Weinh). 2024; 11(13):e2305797.

PMID: 38268241 PMC: 10987166. DOI: 10.1002/advs.202305797.

Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan.

Abbas M, Kashmiri K, Rehman I, Ali Z, Rahman A, Khalil A J Pharm Policy Pract. 2023; 16(1):154.

PMID: 38012805 PMC: 10680351. DOI: 10.1186/s40545-023-00674-6.

References
1.
Gupta K, Hooton T, Naber K, Wullt B, Colgan R, Miller L . International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011; 52(5):e103-20. DOI: 10.1093/cid/ciq257. View
2.
Fleming-Dutra K, Hersh A, Shapiro D, Bartoces M, Enns E, File Jr T . Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016; 315(17):1864-73. DOI: 10.1001/jama.2016.4151. View
3.
Almalki Z, Alahmari A, Guo J, Cavanaugh T . Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012. Pharmacoepidemiol Drug Saf. 2016; 25(9):1042-51. DOI: 10.1002/pds.4021. View
4.
Sanchez G, Babiker A, Master R, Luu T, Mathur A, Bordon J . Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother. 2016; 60(5):2680-3. PMC: 4862481. DOI: 10.1128/AAC.02897-15. View
5.
Chow A, Benninger M, Brook I, Brozek J, Goldstein E, Hicks L . IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012; 54(8):e72-e112. DOI: 10.1093/cid/cir1043. View